Reply to Chen et al. "A Postmarketing Pharmacovigilance Study of Fenfluramine: Adverse Event Data Mining and Analysis Based on the US Food and Drug Administration Public Data Open Project (openFDA)".

Ann Biehl, Lionel Van Holle, Nayla Chaijale, Rebecca Zhang Roper